{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:51:49Z","timestamp":1792889509943,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>TSH receptor autoantibodies (TRAbs) are pathognomonic for Graves\u2019 disease and are thought to also underly the pathogenesis of Graves\u2019 ophthalmopathy (GO). A decline in TRAb levels has been documented post-total thyroidectomy (TTx) in GO, however with conflicting correlations with disease outcomes. The aim of the study was to compare the effectiveness of TTx to other treatment modalities of Graves\u2019 disease and examine whether the lowering of TRAbs is associated with GO improvements.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>We searched electronic databases including Medline, Embase, Scopus, and Web of Science until 31 September 2022 using a broad range of keywords. Patients with GO undergoing TTx with measurements of both TRAbs and progression of the disease using a validated GO scoring system were included. Fourteen studies encompassing data from 1047 patients with GO met our eligibility criteria. The PRISMA guidelines were followed, and five studies had comparable data that were suitable for a meta-analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The Cochrane Risk of Bias tool for RCTs showed low risk of bias across most domains. The pooled odds ratio showed that more patients significantly had normalized TRAb levels post-TTx as compared to other interventions (OR: 1.36, 95% CI: 1.02\u20131.81, <jats:italic>p<\/jats:italic> = 0.035). But, there was no significant difference in GO improvement post-TTx as compared with other intervention groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This meta-analysis shows that TRAb levels may decline largely post-TTx, but may not predict added improvements to the progression of GO. Thus, future studies with uniform designs are required to assess the minimal significant GO improvements.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00423-023-03153-3","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T14:02:32Z","timestamp":1698069752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["TSH receptor autoantibody levels post-total thyroidectomy in Graves\u2019 ophthalmopathy: a meta-analysis"],"prefix":"10.1007","volume":"408","author":[{"given":"Arsalan","family":"Anees","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6827-0088","authenticated-orcid":false,"given":"Femi E.","family":"Ayeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy D.","family":"Eslick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senarath","family":"Edirimanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"issue":"5","key":"3153_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2169\/internalmedicine.53.1518","volume":"53","author":"Y Hiromatsu","year":"2014","unstructured":"Hiromatsu Y, Eguchi H, Tani J, Kasaoka M, Teshima Y (2014) Graves\u2019 ophthalmopathy: epidemiology and natural history. Internal Medicine 53(5):353\u2013360. https:\/\/doi.org\/10.2169\/internalmedicine.53.1518","journal-title":"Internal Medicine"},{"issue":"10","key":"3153_CR2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1089\/105072502761016476","volume":"12","author":"WM Wiersinga","year":"2002","unstructured":"Wiersinga WM, Bartalena L (2002) Epidemiology and prevention of Graves\u2019 ophthalmopathy. Thyroid. 12(10):855\u2013860. https:\/\/doi.org\/10.1089\/105072502761016476","journal-title":"Thyroid."},{"issue":"10","key":"3153_CR3","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1055\/s-0035-1555762","volume":"47","author":"RS Bahn","year":"2015","unstructured":"Bahn RS (2015) Current insights into the pathogenesis of Graves\u2019 ophthalmopathy. Hormone and Metabolic Research 47(10):773\u2013778. https:\/\/doi.org\/10.1055\/s-0035-1555762","journal-title":"Hormone and Metabolic Research"},{"issue":"12","key":"3153_CR4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1055\/a-0739-8134","volume":"50","author":"A Kotwal","year":"2018","unstructured":"Kotwal A, Stan M (2018) Current and future treatments for Graves\u2019 disease and Graves\u2019 ophthalmopathy. Hormone and Metabolic Research 50(12):871\u2013886. https:\/\/doi.org\/10.1055\/a-0739-8134","journal-title":"Hormone and Metabolic Research"},{"issue":"10","key":"3153_CR5","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS et al (2016) 2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 26(10):1343\u20131421. https:\/\/doi.org\/10.1089\/thy.2016.0229","journal-title":"Thyroid."},{"issue":"5","key":"3153_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1507\/endocrj.50.595","volume":"50","author":"Y Takamura","year":"2003","unstructured":"Takamura Y, Nakano K, Uruno T et al (2003) Changes in serum TSH receptor antibody (TRAb) values in patients with Graves\u2019 disease after total or subtotal thyroidectomy. Endocrine Journal 50(5):595\u2013601. https:\/\/doi.org\/10.1507\/endocrj.50.595","journal-title":"Endocrine Journal"},{"key":"3153_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1015-9584(08)60070-6","volume":"31","author":"A Nart","year":"2008","unstructured":"Nart A, Uslu A, Aykas A et al (2008) Total thyroidectomy for the treatment of recurrent Graves\u2019 disease with ophthalmopathy. Asian Journal of Surgery 31:115","journal-title":"Asian Journal of Surgery"},{"issue":"5","key":"3153_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S1479-666X(09)80007-3","volume":"7","author":"AJ Lowery","year":"2009","unstructured":"Lowery AJ, Kerin MJ (2009) Graves\u2019 ophthalmopathy: the case for thyroid surgery. Surgeon. 7(5):290\u2013296. https:\/\/doi.org\/10.1016\/S1479-666X(09)80007-3","journal-title":"Surgeon."},{"issue":"2","key":"3153_CR9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s12020-011-9559-x","volume":"41","author":"A De Bellis","year":"2012","unstructured":"De Bellis A, Conzo G, Cennamo G et al (2012) Time course of Graves\u2019 ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study. Endocrine. 41(2):320\u2013326. https:\/\/doi.org\/10.1007\/s12020-011-9559-x","journal-title":"Endocrine."},{"key":"3153_CR10","doi-asserted-by":"publisher","unstructured":"Liu ZW, Masterson L, Fish B, Jani P, Chatterjee K (2015) Thyroid surgery for Graves\u2019 disease and Graves\u2019 ophthalmopathy. Cochrane Database of Systematic Reviews 2015(11). https:\/\/doi.org\/10.1002\/14651858.CD010576.pub2","DOI":"10.1002\/14651858.CD010576.pub2"},{"key":"3153_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ."},{"key":"3153_CR12","doi-asserted-by":"publisher","unstructured":"Higgins JP, Savovi\u0107 J, Page MJ, Elbers RG, Sterne JA  Assessing risk of bias in a randomized trial. Cochrane Handbook for Systematic Reviews of Interventions. https:\/\/doi.org\/10.1002\/9781119536604.ch8","DOI":"10.1002\/9781119536604.ch8"},{"key":"3153_CR13","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V LM et al. Newcastle-Ottawa Scale for assessing the quality of nonrandomized studies in meta-analysis. Published 2019. https:\/\/www.researchgate.net\/publication\/261773681_The_Newcastle-Ottawa_Scale_NOS_for_Assessing_the_Quality_of_Non-Randomized_Studies_in_Meta-Analysis. Accessed August 16, 2020"},{"issue":"2","key":"3153_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000339473","volume":"1","author":"S Kautbally","year":"2012","unstructured":"Kautbally S, Alexopoulou O, Daumerie C, Jamar F, Mourad M, Maiter D (2012) Greater efficacy of total thyroidectomy versus radioiodine therapy on hyperthyroidism and thyroid-stimulating immunoglobulin levels in patients with Graves\u2019 disease previously treated with antithyroid drugs. Eur Thyroid J 1(2):122\u2013128. https:\/\/doi.org\/10.1159\/000339473","journal-title":"Eur Thyroid J"},{"issue":"4","key":"3153_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/bjs.8660","volume":"99","author":"M Barczy\u0144ski","year":"2012","unstructured":"Barczy\u0144ski M, Konturek A, Hubalewska-Dydejczyk A, Go\u0142kowski F, Nowak W (2012) Randomized clinical trial of bilateral subtotal thyroidectomy versus total thyroidectomy for Graves\u2019 disease with a 5-year follow-up. The British Journal of Surgery 99(4):515\u2013522. https:\/\/doi.org\/10.1002\/bjs.8660","journal-title":"The British Journal of Surgery"},{"key":"3153_CR16","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s002680010216","volume":"24","author":"J Witte","year":"2000","unstructured":"Witte J, Goretzki PE, Dotzenrath C et al (2000) Surgery for Graves\u2019 disease: total versus subtotal thyroidectomy \u2014 results of a prospective randomized trial. World Journal of Surgery 24:1303\u20131311. https:\/\/doi.org\/10.1007\/s002680010216","journal-title":"World Journal of Surgery"},{"issue":"5","key":"3153_CR17","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1210\/jc.2013-3093","volume":"99","author":"M Moleti","year":"2014","unstructured":"Moleti M, Violi MA, Montanini D et al (2014) Radioiodine ablation of postsurgical thyroid remnants after treatment with recombinant human TSH (rhTSH) in patients with moderate-to-severe Graves\u2019 orbitopathy (GO): a prospective, randomized, single-blind clinical trial. The Journal of Clinical Endocrinology and Metabolism 99(5):1783\u20131789. https:\/\/doi.org\/10.1210\/jc.2013-3093","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"3153_CR18","doi-asserted-by":"publisher","unstructured":"Leo M, Marcocci C, Pinchera A et al (2012) Outcome of Graves\u2019 orbitopathy after total thyroid ablation and glucocorticoid treatment: follow-up of a randomized clinical trial. The Journal of Clinical Endocrinology and Metabolism 97(1). https:\/\/doi.org\/10.1210\/jc.2011-2077","DOI":"10.1210\/jc.2011-2077"},{"key":"3153_CR19","doi-asserted-by":"publisher","unstructured":"Domos\u0142awski P, \u0141ukie\u0144czuk T, Forkasiewicz Z et al  Influence of total thyroidectomy on orbital opthalmopathy and levels of antithyroid antibodies in patients with Graves\u2019 disease. Polish Journal of Surgery. https:\/\/doi.org\/10.2478\/v10035-007-0026-6","DOI":"10.2478\/v10035-007-0026-6"},{"issue":"3","key":"3153_CR20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/0002-9610(69)90151-2","volume":"118","author":"B Catz","year":"1969","unstructured":"Catz B, Perzik SL (1969) Total thyroidectomy in the management of thyrotoxic and euthyroid Graves\u2019 disease. American Journal of Surgery 118(3):434\u2013439. https:\/\/doi.org\/10.1016\/0002-9610(69)90151-2","journal-title":"American Journal of Surgery"},{"issue":"7","key":"3153_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1055\/s-0042-108855","volume":"48","author":"M Meyer Zu Horste","year":"2016","unstructured":"Meyer Zu Horste M, Pateronis K, Walz MK et al (2016) The effect of early thyroidectomy on the course of active Graves\u2019 orbitopathy (GO): a retrospective case study. Hormone and Metabolic Research 48(7):433\u2013439. https:\/\/doi.org\/10.1055\/s-0042-108855","journal-title":"Hormone and Metabolic Research"},{"key":"3153_CR22","doi-asserted-by":"publisher","unstructured":"Konturek A, Barczy\u0144ski M, Cicho\u0144 S et al  Total thyroidectomy in treatment of Graves\u2019 ophthalmopathy. Polish Journal of Surgery. https:\/\/doi.org\/10.2478\/v10035-008-0066-6","DOI":"10.2478\/v10035-008-0066-6"},{"issue":"2","key":"3153_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000444796","volume":"5","author":"MF Erdo\u011fan","year":"2016","unstructured":"Erdo\u011fan MF, Demir \u00d6, Ersoy R\u00dc et al (2016) Comparison of early total thyroidectomy with antithyroid treatment in patients with moderate-severe Graves\u2019 orbitopathy: a randomized prospective trial. Eur Thyroid J 5(2):106\u2013111. https:\/\/doi.org\/10.1159\/000444796","journal-title":"Eur Thyroid J"},{"issue":"10","key":"3153_CR24","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1089\/thy.2005.15.1157","volume":"15","author":"J J\u00e4rhult","year":"2005","unstructured":"J\u00e4rhult J, Rudberg C, Larsson E et al (2005) Graves\u2019 disease with moderate-severe endocrine ophthalmopathy-long term results of a prospective, randomized study of total or subtotal thyroid resection. Thyroid. 15(10):1157\u20131164. https:\/\/doi.org\/10.1089\/thy.2005.15.1157","journal-title":"Thyroid."},{"key":"3153_CR25","doi-asserted-by":"publisher","unstructured":"Barrio-Barrio J, Sabater AL, Bonet-Farriol E, Vel\u00e1zquez-Villoria \u00c1, Galofr\u00e9 JC (2015) Graves\u2019 ophthalmopathy: VISA versus EUGOGO classification, assessment, and management. Journal of Ophthalmology 2015. https:\/\/doi.org\/10.1155\/2015\/249125","DOI":"10.1155\/2015\/249125"},{"issue":"2","key":"3153_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/IOP.0000000000000036","volume":"30","author":"M Yang","year":"2014","unstructured":"Yang M, Wiersinga WM, Soeters MR, Mourits MP (2014) What is the aim of immunosuppressive treatment in patients with Graves\u2019 orbitopathy? Ophthalmic Plastic & Reconstructive Surgery 30(2):157\u2013161. https:\/\/doi.org\/10.1097\/IOP.0000000000000036","journal-title":"Ophthalmic Plastic & Reconstructive Surgery"},{"issue":"12","key":"3153_CR27","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1136\/BJOPHTHALMOL-2011-300487","volume":"95","author":"T Fayers","year":"2011","unstructured":"Fayers T, Dolman PJ (2011) Validity and reliability of the TED-QOL: a new three-item questionnaire to assess quality of life in thyroid eye disease. The British Journal of Ophthalmology 95(12):1670\u20131674. https:\/\/doi.org\/10.1136\/BJOPHTHALMOL-2011-300487","journal-title":"The British Journal of Ophthalmology"},{"key":"3153_CR28","doi-asserted-by":"publisher","unstructured":"Kampmann E, Diana T, Kanitz M, Hoppe D, Kahaly GJ (2015) Thyroid stimulating but not blocking autoantibodies are highly prevalent in severe and active thyroid-associated orbitopathy: a prospective study. International Journal of Endocrinology 2015. https:\/\/doi.org\/10.1155\/2015\/678194","DOI":"10.1155\/2015\/678194"},{"issue":"11","key":"3153_CR29","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.ophtha.2011.03.030","volume":"118","author":"KA Ponto","year":"2011","unstructured":"Ponto KA, Kanitz M, Olivo PD, Pitz S, Pfeiffer N, Kahaly GJ (2011) Clinical relevance of thyroid-stimulating immunoglobulins in Graves\u2019 ophthalmopathy. Ophthalmology. 118(11):2279\u20132285. https:\/\/doi.org\/10.1016\/j.ophtha.2011.03.030","journal-title":"Ophthalmology."},{"issue":"6","key":"3153_CR30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1210\/jcem-50-6-1005","volume":"50","author":"CS Teng","year":"1980","unstructured":"Teng CS, Yeung RTT, Khoo RKK, Alagaratnam TT (1980) A prospective study of the changes in thyrotropin binding inhibitory immunoglobulins in Graves\u2019 disease treated by subtotal thyroidectomy or radioactive iodine*. The Journal of Clinical Endocrinology and Metabolism 50(6):1005\u20131010. https:\/\/doi.org\/10.1210\/jcem-50-6-1005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"7","key":"3153_CR31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1089\/THY.2010.1634","volume":"20","author":"MN Stan","year":"2010","unstructured":"Stan MN, Bahn RS (2010) Risk factors for development or deterioration of Graves\u2019 ophthalmopathy. Thyroid. 20(7):777. https:\/\/doi.org\/10.1089\/THY.2010.1634","journal-title":"Thyroid."},{"issue":"6","key":"3153_CR32","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/BJO.87.6.773","volume":"87","author":"A Eckstein","year":"2003","unstructured":"Eckstein A, Quadbeck B, Mueller G et al (2003) Impact of smoking on the response to treatment of thyroid associated ophthalmopathy. The British Journal of Ophthalmology 87(6):773\u2013776. https:\/\/doi.org\/10.1136\/BJO.87.6.773","journal-title":"The British Journal of Ophthalmology"},{"issue":"6","key":"3153_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1365-2265.1982.tb03170.x","volume":"16","author":"S Atkinson","year":"1982","unstructured":"Atkinson S, McGregor AM, Kendall-Taylor P, Peterson MM, Smith BR (1982) Effect of radioiodine on stimulatory activity of Graves\u2019 immunoglobulins. Clinical Endocrinology 16(6):537\u2013543. https:\/\/doi.org\/10.1111\/j.1365-2265.1982.tb03170.x","journal-title":"Clinical Endocrinology"},{"issue":"1","key":"3153_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1530\/EJE-07-0450","volume":"158","author":"P Laurberg","year":"2008","unstructured":"Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, T\u00f6rring O (2008) TSH-receptor autoimmunity in Graves\u2019 disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. European Journal of Endocrinology 158(1):69\u201375. https:\/\/doi.org\/10.1530\/EJE-07-0450","journal-title":"European Journal of Endocrinology"},{"issue":"1","key":"3153_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4183\/aeb.2017.72","volume":"13","author":"Q Dong","year":"2017","unstructured":"Dong Q, Liu X, Wang F et al (2017) Dynamic changes of TRAb and TPOAb after radioiodine therapy in Graves\u2019 disease. Acta Endocrinologica 13(1):72\u201376. https:\/\/doi.org\/10.4183\/aeb.2017.72","journal-title":"Acta Endocrinologica"},{"key":"3153_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/FENDO.2016.00167","volume":"7","author":"TJ Smith","year":"2016","unstructured":"Smith TJ, Janssen JAMJL (2016) Building the case for insulin-like growth factor receptor-I involvement in thyroid-associated ophthalmopathy. Front Endocrinol (Lausanne) 7:1. https:\/\/doi.org\/10.3389\/FENDO.2016.00167","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"3153_CR37","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1172\/JCI113672","volume":"82","author":"L Brenner-Gati","year":"1988","unstructured":"Brenner-Gati L, Berg KA, Gershengorn MC (1988) Thyroid-stimulating hormone and insulin-like growth factor-1 synergize to elevate 1,2-diacylglycerol in rat thyroid cells. Stimulation of DNA synthesis via interaction between lipid and adenylyl cyclase signal transduction systems. Journal of Clinical Investigation 82(3):1144. https:\/\/doi.org\/10.1172\/JCI113672","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"3153_CR38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1677\/JME.0.0300369","volume":"30","author":"KJ Starkey","year":"2003","unstructured":"Starkey KJ, Janezic A, Jones G, Jordan N, Baker G, Ludgate M (2003) Adipose thyrotrophin receptor expression is elevated in Graves\u2019 and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. Journal of Molecular Endocrinology 30(3):369\u2013380. https:\/\/doi.org\/10.1677\/JME.0.0300369","journal-title":"Journal of Molecular Endocrinology"},{"issue":"2","key":"3153_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/S41574-019-0305-4","volume":"16","author":"PN Taylor","year":"2020","unstructured":"Taylor PN, Zhang L, Lee RWJ et al (2020) New insights into the pathogenesis and nonsurgical management of Graves orbitopathy. Nature Reviews. Endocrinology 16(2):104\u2013116. https:\/\/doi.org\/10.1038\/S41574-019-0305-4","journal-title":"Nature Reviews. Endocrinology"},{"issue":"5","key":"3153_CR40","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1089\/THY.2017.0105","volume":"27","author":"CC Krieger","year":"2017","unstructured":"Krieger CC, Neumann S, Marcus-Samuels B, Gershengorn MC (2017) TSHR\/IGF-1R cross-talk, not IGF-1R stimulating antibodies, mediates Graves\u2019 ophthalmopathy pathogenesis. Thyroid. 27(5):746. https:\/\/doi.org\/10.1089\/THY.2017.0105","journal-title":"Thyroid."},{"issue":"12","key":"3153_CR41","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1007\/s40618-021-01544-1","volume":"44","author":"G Lanzolla","year":"2021","unstructured":"Lanzolla G, Menconi F, Nicol\u00ec F et al (2021) Beneficial effect of low-dose radioiodine ablation for Graves\u2019 orbitopathy: results of a retrospective study. Journal of Endocrinological Investigation 44(12):2575\u20132579. https:\/\/doi.org\/10.1007\/s40618-021-01544-1","journal-title":"Journal of Endocrinological Investigation"},{"issue":"4","key":"3153_CR42","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1001\/archotol.128.4.389","volume":"128","author":"N Bhattacharyya","year":"2002","unstructured":"Bhattacharyya N, Marvin PF (2002) Assessment of the morbidity and complications of total thyroidectomy. Archives of Otolaryngology. Head & Neck Surgery 128(4):389\u2013392. https:\/\/doi.org\/10.1001\/archotol.128.4.389","journal-title":"Head & Neck Surgery"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-03153-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-023-03153-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-03153-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T16:25:18Z","timestamp":1705595118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-023-03153-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3153"],"URL":"https:\/\/doi.org\/10.1007\/s00423-023-03153-3","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]},"assertion":[{"value":"20 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"415"}}